Inorganic arsenic methylation capacity and breast cancer by immunohistochemical subtypes in northern Mexican women
- PMID: 32209496
- DOI: 10.1016/j.envres.2020.109361
Inorganic arsenic methylation capacity and breast cancer by immunohistochemical subtypes in northern Mexican women
Abstract
Background: Previously we reported that inorganic arsenic (iAs) methylation capacity was associated with breast cancer (BC). BC risk factors may vary according to immunohistochemical subtype. Here we explored the relationships between the capacity to methylate iAs and the risk of BC by subtype.
Methods: A population-based case-control study was performed in northern Mexico. Patients with available information about BC subtypes (n = 499) were age-matched with healthy controls. Sociodemographic, reproductive, and lifestyle characteristics were obtained. Tumor marker information was obtained from medical records. Cases were classified as HR+ [estrogen receptor (ER+) and/or progesterone (PR+), and human epidermal growth factor receptor 2 (HER2-)], HER2+, or triple negative (TN). Urinary arsenic species were determined by high performance liquid chromatography inductively coupled plasma mass spectrometry (HPLC-ICP-MS), and methylation capacity parameters calculated. Conditional logistic regression models were used to estimate BC risk by subtypes.
Results: Urinary total arsenic varied from 0.60 to 303.29 μg/L. A significant positive association was found between % monomethylarsonic acid (%MMA) and HR + BC: one percent increase resulted in OR%MMA continuous = 2.73, 95% CI: 1.48, 5.05), and this association remained even when %iAs or % dimethylarsinic acid (%DMA) were added to the models with %MMA. MMA/iAs was positively associated with HR + BC (ORMMA/iAs continuous = 2.03, 95% CI: 1.33-3.10). A significant negative association was observed between DMA/MMA and HR + BC (ORDMA/MMA continuous = 0.43, 95% CI: 0.26, 0.71). MMA/iAs was positively associated with TN BC (OR MMA/iAs continuous = 4.05; 95% CI: 1.63, 10.04).
Conclusion: Altered iAs methylation capacity resulting in higher %MMA was associated with HR+ and TN BC but not with HER2+. MMA is the iAs metabolite more likely to be related to BC. Further research is needed to confirm these results and elucidate the underlying biological mechanisms.
Keywords: Breast cancer; HER2; Hormonal receptor; Inorganic arsenic; Triple negative.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declarations of competing interest None.
Similar articles
-
Arsenic methylation capacity is associated with breast cancer in northern Mexico.Toxicol Appl Pharmacol. 2014 Oct 1;280(1):53-9. doi: 10.1016/j.taap.2014.07.013. Epub 2014 Jul 22. Toxicol Appl Pharmacol. 2014. PMID: 25062773
-
Sex differences in the reduction of arsenic methylation capacity as a function of urinary total and inorganic arsenic in Mexican children.Environ Res. 2016 Nov;151:38-43. doi: 10.1016/j.envres.2016.07.020. Epub 2016 Jul 21. Environ Res. 2016. PMID: 27450997
-
Children exposure to inorganic and organic arsenic metabolites: A cohort study in Northeast Italy.Environ Pollut. 2020 Oct;265(Pt B):114826. doi: 10.1016/j.envpol.2020.114826. Epub 2020 May 16. Environ Pollut. 2020. PMID: 32454361
-
The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):458-67. doi: 10.1016/j.taap.2003.10.023. Toxicol Appl Pharmacol. 2004. PMID: 15276427 Review.
-
Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.Crit Rev Toxicol. 2006 Feb;36(2):99-133. doi: 10.1080/10408440500534230. Crit Rev Toxicol. 2006. PMID: 16736939 Review.
Cited by
-
Arsenic and Benzo[a]pyrene Co-exposure Effects on MDA-MB-231 Cell Viability and Migration.Biol Trace Elem Res. 2024 Apr 11. doi: 10.1007/s12011-024-04170-z. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38602648
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
In silico comparative structural and functional analysis of arsenite methyltransferase from bacteria, fungi, fishes, birds, and mammals.J Genet Eng Biotechnol. 2023 May 19;21(1):64. doi: 10.1186/s43141-023-00522-9. J Genet Eng Biotechnol. 2023. PMID: 37204693 Free PMC article.
-
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults.Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012649. doi: 10.1002/14651858.CD012649.pub2. Cochrane Database Syst Rev. 2021. PMID: 34661903 Free PMC article. Review.
-
Nutrition, one-carbon metabolism and arsenic methylation.Toxicology. 2021 Jun 15;457:152803. doi: 10.1016/j.tox.2021.152803. Epub 2021 Apr 24. Toxicology. 2021. PMID: 33905762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous